Results 181 to 190 of about 86,432 (312)

Implantable Cardioverter-Defibrillators [PDF]

JAMA, 2006
Janet M. Torpy, Cassio Lynm, Richard M. Glass   +2 more
openaire   +2 more sources

Public Electric Baths in Japan: A Risk of Inappropriate Implantable Cardioverter-Defibrillator Shock. [PDF]

J Arrhythm
Ido T, Nakashima T, Yamaura M, Takahashi S, Aoyama T.   +4 more
europepmc   +1 more source

The Free‐Falling Needle: A Case Report of an Accidental Iatrogenic Pneumothorax

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT This case highlights the potential for accidental iatrogenic pneumothorax during routine procedures, like breast cyst aspiration, and emphasizes the importance of strict procedural precautions to avoid such incidents.
Abdul Qadir, Amal Wael Abdellatif, Elmukhtar Habas, Mamunul Islam   +3 more
wiley   +1 more source

Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter‐defibrillator therapies and hospitalizations

European Journal of Heart Failure, 2018
M. Gasparini, A. Kloppe, M. Lunati, F. Anselme, M. Landolina, J. Martínez‐Ferrer, A. Proclemer, G. Morani, M. Biffi, R. Ricci, R. Rordorf, L. Mangoni, L. Manotta, A. Grammatico, F. Leyva, G. Boriani   +15 more
semanticscholar   +1 more source

Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?

The Journal of Physiology, EarlyView.
Jean‐Pierre Benitah, Esther Zorio, Ana María Gómez   +2 more
wiley   +1 more source

Daily Remote Monitoring of Pediatric Patients With Cardiac Implantable Electronic Devices: Early Arrhythmia Detection and Timely Clinical Intervention

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT In recent years, significant progress has been made in the management of pediatric arrhythmias through the use of cardiac implantable electronic devices (CIEDs) such as pacemakers (PMs) and implantable cardioverter‐defibrillators (ICDs).
Piotr Wieniawski, Jakub Zabłocki, Bożena Werner   +2 more
wiley   +1 more source

Six‐year follow‐up of the initial Dutch subcutaneous implantable cardioverter‐defibrillator cohort: Long‐term complications, replacements, and battery longevity

Cardiovascular Electrophysiology, 2018
A. Quast, V. V. van Dijk, S. Yap, A. Maass, L. Boersma, D. Theuns, R. Knops   +6 more
semanticscholar   +1 more source

Extravascular implantable cardioverter-defibrillator implantation in a teenager with Brugada syndrome and recurrent inappropriate shocks of subcutaneous implantable cardioverter-defibrillator. [PDF]

HeartRhythm Case Rep
Garibaldi S, Aimo A, Concistrè G, Nesti M, Panchetti L, Startari U, Mirizzi G, Santoro G, Piacenti M, Rossi A.   +9 more
europepmc   +1 more source

Survival and Clinical Progression in Barth Syndrome: Insights From the Barth Syndrome Foundation's Database of 502 Affected Individuals

Journal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT Barth syndrome (BTHS; OMIM 302060) is an ultra‐rare, life‐limiting genetic disorder characterized by cardiomyopathy, skeletal muscle myopathy, neutropenia, gastrointestinal issues, and fatigue. Formal analyses of survival and clinical progression remain limited.
Kexin Fu, Yonglin Huang, Valerie Bowen, Katherine McCurdy, Reina B. Tan, Colin K. L. Phoon, Lindsay Marjoram, Alex Dahlen   +7 more
wiley   +1 more source

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

New England Journal of Medicine, 2004
S. Hohnloser, K. Kuck, P. Dorian, R. Roberts, J. Hampton, R. Hatala, E. Fain, M. Gent, S. Connolly   +8 more
semanticscholar   +1 more source